| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 861 | 694 | 502 | 200 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 1.591 | 718 | 551 | 213 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 1.897 | 1.885 | 2.424 | 1.278 | 769 | 115 | 104 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -306 | -1.167 | -1.873 | -1.065 | -769 | -115 | -104 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -353 | -1.188 | -1.888 | -1.071 | -769 | -115 | -104 | 0 | 0 | 0 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - O.s.c. Laboratories Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 428 | 220 | 17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 12.546 | 11.447 | 8.961 | 7.659 | 6.742 | 6.500 | 6.252 | 6.272 | 6.253 | 6.218 |
| Inventories | 1.724 | 1.516 | 1.490 | 1.463 | 1.434 | 1.407 | 1.376 | 1.380 | 1.376 | 1.368 |
| Receivables | 1.880 | 1.670 | 1.138 | 5.512 | 5.225 | 5.011 | 4.858 | 4.874 | 4.859 | 4.832 |
| Cash | 8.943 | 8.261 | 6.333 | 684 | 83 | 82 | 18 | 18 | 18 | 17 |
| Shareholders Funds | 12.281 | 10.967 | 8.894 | 7.659 | 6.742 | 6.500 | 6.252 | 6.272 | 6.253 | 6.218 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 694 | 700 | 84 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7220 - 7220" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - O.s.c. Laboratories Srl